QRX

AcronymDefinition
QRXWait-Call Again At ...
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Schlieder and Meuss presented the QRX [6] which is based on tree matching without knowing the exact structure of the data of the similarity measure of the vector space model; an element score is computed as follows:
QRxPharma (ASX: QRX and OTCQX: QRXPY) is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of therapies for pain management and central nervous system (CNS) disorders.
More detailed information about a specific drug is available via the link to qRx.
Determining brand name and renal dosing recommendations requires bridging to qRx.
About 87% of the respondents reporting using the ePocrates qRx program as a drug reference.
Envision said it expects to invest approximately USD 135m to acquire Questcare Medical Services and QRx Medical Management.
QRx Medical Management provides financial and administrative services to support Questcare's clinical operations.
QRxPharma (ASX: QRX), Sydney, Australia, has announced that a number of patients have been treated in the first of several clinical studies to be conducted as part of the Phase III development program for its lead product candidate Q8003IR, an immediate release dual-opioid pain therapy.
Target: Questcare Medical Services, P.A., QRx Medical Management, LLC
2 September 2010 - Australian specialty pharmaceutical company QRxPharma (ASX: QRX) reported on Wednesday a successful interim analysis of its final MoxDuo IR pivotal Phase III study required for New Drug Application (NDA) submission.
9 August 2010 - Australia-based clinical-stage specialty pharmaceutical company QRxPharma Limited (ASX: QRX) announced today positive results of its Phase II comparative proof-of-concept study to evaluate the efficacy and safety of its IV (intravenous) formulation of morphine plus oxycodone versus IV morphine alone for the treatment of moderate to severe post-operative pain in patients following hip replacement surgery.
10 February 2010 - Australian QRxPharma Limited (ASX: QRX) said today it has commenced its second pivotal Phase III registration trial (Study 009) to evaluate analgesic efficacy and safety of MoxDuo IR, a patented 3:2 ratio fixed dose combination of morphine plus oxycodone.